- Research article
- Open Access
- Open Peer Review
Should chronic hepatitis B mothers breastfeed? a meta analysis
© Zheng et al; licensee BioMed Central Ltd. 2011
- Received: 3 March 2011
- Accepted: 27 June 2011
- Published: 27 June 2011
Hepatitis B virus (HBV) exists in the breast milk of chronic hepatitis B (CHB) mothers. The authors use a meta-analytic technique to quantify the evidence of an association between breastfeeding and risk of CHB infection among the infants vaccinated against HBV.
Literature search is performed up to 2010 on the relationship between infantile CHB infection within one-year follow up after immunization with the third-dose hepatitis B vaccine and breastfeeding. Two reviewers independently extract the data and evaluate the methodological quality. A random-effects model is employed to systematically combine the results of all included studies.
Based on data from 32 studies, 4.32% (244/5650) of infants born of CHB mothers develop CHB infection. The difference in risk of the infection between breastfed and formula-fed infants (RD) is -0.8%, (95% confidence interval [CI]: -1.6%, 0.1%). Analysis of the data from 16 of the studies finds that RD for mothers who are positive for the HBeAg and/or the HBV DNA, 0.7% (95%CI: -2.0%, 3.5%), is similar to that for those who are negative for these infectivity markers, -0.5% (95%CI: -1.7%, 0.6%).
Breast milk is infectious; yet, breastfeeding, even by mothers with high infectivity, is not associated with demonstrable risk of infantile CHB infection, provided that the infants have been vaccinated against HBV at birth.
- Risk Difference
- Infectivity Marker
- Chinese BioMedical Literature Database
- Routine Hepatitis
The hepatitis B virus (HBV) accounts for a significant morbidity and mortality worldwide. An estimated one-third of the world population has been exposed to HBV and 400 million people are chronic carriers . Mother to infant transmission of HBV would occur among up to 90% of infants born of chronic hepatitis B (CHB) mothers who are positive for the infectivity markers, the HBeAg and/or the HBV DNA . With the introduction of a safe and effective hepatitis B vaccine, infantile CHB infection has dramatically dropped to around 5% .
The advantages of breastfeeding over formula feeding have been well documented . However, the presence of the HBV in breast milk firstly reported by Linnemann  in 1974 and confirmed by later studies [6, 7] raised the possibility of transmission of HBV through breastfeeding. But later studies found no association between breastfeeding and infantile CHB infection, both before and after the introduction of hepatitis B vaccine [8–13]. In the absence of evidence that breastfeeding poses any additional risk of infection to infants born of CHB mothers, World Health Organization (WHO) recommends breastfeeding even for area where HBV infection is highly endemic and HBV vaccine is not available .
Scepticism about this recommendation remains among clinicians, however. About 25% of obstetricians in Australia  and 50% of physicians (most of them were hepatologists!) in Illinois  did not recommend CHB mothers to breastfeed their babies. It was noted that 5.4% of pregnant women in Shanghai were HBsAg positive and 30.3% of whom were HBeAg-positive (Tao, personal communication), which was reported to pose a significant risk of HBV transmission to infants, including those who had been vaccinated against the virus . In the light of this and other studies , it is a common and recommended practice that CHB mothers with an abnormal alanine aminotransferase (ALT) level before delivery do not breastfeed.
In the present paper, we conduct a meta analysis to assess the risk of CHB infection of vaccinated infants through breastfeeding associating with CHB mothers who are and are not positive for the HBV infectivity markers.
Data sources and search strategy
Two independent investigators (Ye and Zhou) searched PubMed (1966-), Chinese BioMedical Literature database (CBM, 1978-), Chinese National Knowledge Infrastructure (CNKI, 1979-) and Wanfang Data (Wanfang, 1998-) up to December 31th, 2010 by using the combination of MeSH terms "breast feeding" or "breastfeeding" and "hepatitis B". In addition, the reference lists of potentially relevant manuscripts were scanned backward to obtain extra eligible studies.
Criteria for inclusion of the studies
(1) Follow-up studies, prospective or retrospective, on the association between breastfeeding (BF) versus formula-feeding (FF) and risk of CHB infection among the infants born of CHB mothers.
(2) All infants must receive at least 3 doses of hepatitis B vaccines, with or without receiving hepatitis B immunoglobulin (HBIG) after birth.
(3) CHB infection is defined as the presence of any of the three HBV markers (HBsAg, HBeAg and HBV DNA) in blood, during prenatal care visit and/or before delivery of their babies for the mothers and within one year after immunization with the third-dose hepatitis B vaccine for the infants.
Two independent investigators (Xia and Yao) were involved in data extraction. The third investigator (Lu) examined the results, and a consensus was reached. The outcome, CHB infection of the infants born of CHB mothers at the end of follow-up within one year after immunization with the third-dose hepatitis B vaccine was considered. We extracted the following data from the eligible studies: authors' names, journal and year of publication, country of origin, enrolment periods, type of study, number of CHB and non-CHB among the infants by feeding methods, general characteristics of the babies and their mothers.
Assessment of methodological quality
General characteristic and quality score of the 32 studies included in this meta analysis
Author, publication year and NOS
Mothers enrolled period and sites
Number of infants, length of follow up and types of study
Characteristic of the mothers*1
Characteristic of the babies
APCW, S+ and C+; a normal pregnancy; informed consent.
Normal ALT and birth weight.
0.5 ml/kg HBIG/8 h + 1 ml(P)/2-4-11 m
Sex ratio of 1.2, no medication except a multivitamin mixture, vaccination against polio, tetanus and diphtheria; monthly visit, no dropout; no vaccine-related serious side effect and no abnormal ALT was observed at the end of follow up.
Mothers' E+% and newborns' gender were similar between BF and FF.
64(E) among BF
0.5 ml HBIG/24 h + 5 μg (P)/0-1-6 m
Aug. 1989-Sept. 1990
S+% = 6.4 and E+% = 25.6 (U) at birth.
30 μg(P)/0-1-6 m
Average age of the mothers was 26.97 ± 2.83 years old.
55.6(E) among BF
Full-term normal delivery.
200IU HBIG/4 h,1 m +30 μg(P)/1-3-6 m.
Mothers' age were similar between BF and FF.
Jan. 1996-Jun. 1999
PCW, S+; normal ALT.
S+% = 14.9(U, 134cases) at birth.
10 μg (R)/0-1-6 m
Mothers' E+% was higher in FF than BF.
Jan. 1995-Dec. 2000
PCW, S+; normal hepatic function; no nipple crack; 200IU-HBIG treatment.
Complete gestation birth; no oral ulcer.
200IU HBIG/4 h,1 m+10 μg (R)/1-3-6 m with booster.
Mothers' age range was 25-31 years.
Jan. 1992-Sept. 1998
Texas, The United States
PCW, S+, CG+ and CM-
24.5(E, 179 cases)
0.5 ml HBIG+ 0-1-6 mwith booster.
Complete follow-up and vaccination; mothers' nulliparous% (all cases), AST/ALT level, anti-HCV+%, HIV-1+%, E+%, CG+% and CM+% based on available cases, and newborns' gender were similar between BF and FF.
Mothers were younger and with more blacks in FF than BF.
APCW, S+; normal ALT.
37-42 gestation weeks; S+% = 10.9 at birth.
30 μg(P, before 1997) or 5 μg(R, after 1997)/0-1-6 m or/24 h+1-2-7 m
Those infants were excluded with an obvious abnormality, birth weight < 2500 g, or an apgar score of < 8 at 1 or 5 minutes.
Mothers' E+%, newborns' gender, birth weight and S+% at birth were similar between BF and FF.
BF group received more active immunization than FF.
May 1995-Sept. 1997
100(E or DNA)
200IU HBIG/24 h+30 μg(P)/2 w,10 μg/1.5 m, 10 μg/6.5 m
Duration of breastfeeding < 4 months was excluded.
PCW, S+ and c+; 200~400IU-HBIG treatment
Healthy; complete gestation weeks; birth weight > 3000 g; S+% = 7.6 at birth.
10 μg(R, 80 cases) or 30 μg (P, 72 cases)/24 h-1-6 m
Proportion of types of vaccines was similar between BF and FF.
Dec. 1997-Dec. 1999
Inner Mongolia, China
DNA+% = 56(U)
100-200IU HBIG/6 h, 2 w+ 0-1-6 m
Feb. 1998-Feb. 2001
APCW, S+; 200IU-HBIG treatment.
S+% = 8.7 and E+% = 0.9 at birth
200IU HBIG/24 h, 2 w+5 μg(R)/0-1-6 m
Newborns' S+% and E+% at birth were similar between BF and FF.
Dec. 2000-Jun. 2002
PCW, S+; 200IU-HBIG treatment.
Healthy; complete gestation weeks; DNA+% = 5.0 and S+% = 6.3 at birth.
200IU HBIG/6-12 h,2 w+5 μg(R)/0-1-6 m
Mothers' age, uterine contraction+%, duration of uterine contraction, E+% and HBV+%, and newborns' gestation weeks and birth weight were similar between BF and FF.
Mar. 2001-Mar. 2003
PCW, S+; normal ALT; 200IU-HBIG treatment (66 cases).
S+% = 16.4, E+% = 6.7 and DNA+% = 2.2 at birth.
No foetus abnormality, no history of treatment of anti-virus drugs during pregnancy, TORCH syndrome and other diseases.
Sept. 2001-Oct. 2003
PCW, S+; normal hepatic function; informed consent.
DNA+% = 13.2 (U) at birth.
200IU HBIG/12 h,2 w+0-1-6 m with booster.
Exclusion for those with premature birth, low birth weight, asphyxia and history of bleeding during pregnancy, breastfeed < 1 month.
Mothers' E+% and DNA+%, newborns' gestation weeks, birth weight and DNA+% (U) were similar between BF and FF.
PCW, S+; 200IU-HBIG treatment.
200IU HBIG/24 h, 1 m+10 μg(R)/2-3-6 m
Natural delivery% = 50.0
Jan. 2001-Feb. 2002
PCW, S+; 100IU-HBIG treatment.
200IU HBIG/24 h+100IU HBIG/15d+10 μg(R)/2-3-6 m
Mothers' E+% was higher in FF than BF.
Dec. 2002-Mar. 2004
PCW, S+; normal hepatic function; no nipple crack; 200IU-HBIG treatment.
Healthy; complete gestation weeks.
200IU HBIG/6 h+5 μg (R)/12 h-1-6 m
Mothers' age and DNA+%, newborns' gestation weeks were similar between BF and FF.
Jun. 2001-Dec. 2003
PCW, S+; normal ALT; 200IU-HBIG treatment.
Apgar > 7; birth weight > 2500 g; S+% = 12.2 at birth.
200IU HBIG/24 h, 1 m+ 5 μg (R)/72 h-1-6 m
Mothers' E+%, newborns' gender, birth weight and HBV+% at birth were similar between BF and FF.
Birth temperature < 37°C; birth weight > 2500 g; apgar > 8.
Mothers' E+% was similar between BF and FF.
Mar. 2002-May. 2005
APCW, S+; normal hepatic function; informed consent.
DNA+% = 9.4(U).
200IU HBIG/12 h,14 d+5 μg(R)/0-1 -6 m with booster
Exclusion for those with premature birth, low birth weight, asphyxia and history of bleeding during pregnancy, breastfeeding below one month.
Mothers' E+% and DNA+%, newborns' birth weight, gestation weeks and DNA+% were similar between BF and FF.
May 2004-May 2005
PCW, S+; 200IU-HBIG treatment.
S+% = 6.7 and DNA+% = 4.2 at birth.
200IU HBIG/48 h,1 m,3 m+5 μg(R)/24 h-1 -6 m
The infants were randomized into two groups.
Mothers' age, E+% and DNA+%, newborns' birth weight, method of delivery, S+% and DNA+% were similar between BF and FF.
Oct. 2003-Jan. 2006
S+% = 11.5 and E+% = 2.4.
200IU HBIG/6 h+5 μg(R)/2 d-1-6 m
Mothers' age and DNA level, newborns' sex ratio, birth weight and method of delivery were similar between BF and FF.
Jan. 2001-Jan. 2005
PCW, DNA+; 200IU-HBIG treatment.
DNA+% = 4.5 at birth
200IU HBIG/16 h+10 μg(R)/1-2-7 m or 10 μg(R)/0-1-6 m
Oct. 2002-Aug. 2007
0(E and DNA)
10 μg(R)/0-1-6 m+ 100-200IU HBIG/24 h, 15-30d(241 cases).
Proportion of infants who received HBIG was higher in FF than BF.
PCW, S+; abnormal ALT/AST% = 2.2.
100IU HBIG/1 d+5 μg(R)/0-1-6 m with booster.
Mothers' age, abnormal ALT/AST%, E+%, CM+% and CG+%, newborns' sex ratio were similar between BF and FF.
APCW, S+; normal hepatic function; 200IU-HBIG treatment.
DNA+% = 10.0 at birth.
200 IU HBIG/12 h, 2 w+ 0-1-6 m with booster.
Mothers' E+% and DNA+%, newborns' gestation weeks, birth weight and DNA+% were similar between BF and FF.
PCW, S+; normal hepatic function; 200IU-HBIG treatment.
200 IU HBIG/12 h, 2 w+5 μg(R)/0-1-6 m
Mothers' E+% and DNA+% were higher in FF than BF.
PCW, S+; 200IU-HBIG voluntary treatment.
200IU HBIG/24 h,2 w or 200IU HBIG/24 h +0-1-6 m or 0-1-2-7 m
Mothers' age range was 21-40 years old.
Nov. 2007-Jul. 2008
Jan. 2009-Mar. 2010
PCW, S+; 200IU-HBIG treatment.
200IU HBIG+5 μg (R)/0-1-6 m
Mothers' DNA+%, age, time of pregnancy and delivery, methods of delivery, newborns' birth weight, S+% and DNA+% at birth were similar between BF and FF.
Sept. 2007-May. 2009
100 (both E and DNA)
200IU HBIG/6 h+5 μg(R)/0-1-6 m
Mothers' age, newborns' sex ratio, birth weight and methods of delivery were similar between BF and FF.
The risk difference (RD) with 95% confidence interval (CI) was used as a measure of effect between breastfeeding (BF) versus formula-feeding (FF) and risk of infantile CHB infection across studies. The Dersimonian and Laird random-effects model was used to pool the RDs across studies in Stata version 10.0 (Stata Corp). Heterogeneity was explored by χ2 test, with a significance set at a P value < 0.10. The extent of heterogeneity was measured by Higgins' I2. Subgroup analysis and Meta-regression were carried out to examine the effect in relation to quality and type of study, language of paper, study sites, hepatitis B vaccination of the mothers and infants, and mothers' infectivity if available. We used the test for interaction to estimate the difference between two subgroups . Publication bias was assessed by visual inspection of a funnel plot, the Egger's and Begger's test , and a nonparametric trim and fill method was performed .
1. Literature search
The search retrieved 517 papers, and 99 out of which were potentially relevant to current analysis. Further backward search produced 3 additional papers. Only 32 papers [7, 10–13, 22–48] which offered 32 independent studies were included in our analysis and the reasons for exclusion of the others were listed in Additional file 1-Figure S1.
2. General characteristics about the studies included in meta analysis
The 32 studies included in present analysis were published between 1985 and 2010 (Table 1). One study was conducted in the United States , one in Italy  and the other 30 in China, including Hongkong. Mothers decided the feeding methods in all studies except one in which they were randomized . The sample size of the studies ranged from 38 to 436 (median, 143), with the ratio of BF versus FF infants of 0.09-5.07 (median, 0.94).
3. The risk difference (RD) of infantile CHB infection with methods of feeding
Proportion of the mothers with high infectivity overall, by language and quality of papers
No of high infectivity/
high infectivity (%)
No of high infectivity/
high infectivity (%)
Language of papers
Quality of papers
4. Publication bias and its correction
Our results suggest that breastfeeding by CHB mothers does not pose a significant risk of infection by the virus, provided that the infants have been vaccinated against HBV at birth.
In this meta analysis, the overall transmission rate of HBV from CHB mothers to their infants who had completed routine hepatitis B vaccination was 4.32%, which was similar to those previously reported . Mother-to-infant transmission of HBV can occur prenatally, at birth and postnatally , but most commonly infection occurs at the time of delivery. In-utero transmission is very uncommon, except in China and Japan, and often persists after birth, which results in the ineffectiveness of HBV vaccination, i.e., immunoprophylaxis [49, 50]. From this perspective, most mother-to-infant transmission occurs before deciding on infant feeding methods. But there is an exception: the neonate can be infected postnatally by household contact with CHB family members . Apparently, breastfeeding would produce more frequent contacts between mother and infant than formula-feeding. Though separation of breastfed transmission of CHB from contact seems to be important in the clarification of the net effect of breastfeeding on infantile CHB infection, this contact transmission occurs only at the successful exchange of body fluid from infected mothers to their infants under some special situations, such as excoriation. Thus breastfed transmission of HBV, if existed, should be minimal.
Two previous meta analyses reported different associations of breastfeeding and infantile CHB infection with an odds ratio (OR) = 1.68 (95%CI: 1.16, 2.44)  and 0.67 (95%CI: 0.41, 1.12)  respectively based on 13 and 10 studies. The inconsistent results reflected difference between the studies with respect to their study aim, search strategies, criteria of inclusion and exclusion of the studies, and analysis strategies. One study included both vaccinated and not vaccinated infants  and the other included only those who had been given both passive and active immunization . After careful evaluation on these two analyses, we identified their obvious shortcomings: (1) many eligible studies were not included in these analyses without any reason; (2) the analyses excluded those studies with zero outcome of infantile CHB infection in both groups of feeding methods; (3) neither of the studies evaluated the quality of the included studies and their influence on the results, and (4) neither of the studies considered the possible confounding of mothers' infectivity, which was important in mother-to-infant transmission of HBV and their decisions on how to feed their infants [17, 54]. In our meta analysis, reference search, data extraction and quality evaluation were done by two independent investigators and examined by the third one before a consensus was reached, thus the completeness and appropriateness of the studies included for analysis were ensured. We used RD instead of OR or risk ratio (RR) as effect measure, which ensured that a reasonable estimation of effect measurement remained untouched and the 2nd shortcoming mentioned above was overcome simultaneously.
Our findings have important implications for current clinical practice about breastfeeding by CHB mothers, even with high infectivity. Routine hepatitis B vaccination allows the infant to enjoy breastfeeding, the nutritional, immunological and psychological advantages of which are well known. And breastfeeding would also greatly benefit the mother, especially in weakening or eliminating her fear and guilt which occur often. Unfortunately, contrary to our findings that risk of breastfed transmission of infantile CHB infection simply does not exist, the current clinical practices seem discouraging: (1) any breastfeeding rate is about 30% lower for those mothers with than without CHB , and even lower (5.4% only) for those with high infectivity ; (2) there is still 25%-50% of the medical professionals did not recommend infantile breastfeeding by CHB mothers [15, 16]. Thus, health education of breastfeeding with correct knowledge, attitude and behaviour on the decision makers, such as medical professional and CHB mothers, seems to be urgent, especially in those epidemic countries, like China.
This meta analysis demonstrates no association between breastfeeding and risk of infantile CHB infection from a CHB mother to her infant. Two alternative explanations must be considered. First, a systematic bias may be present in follow-up studies arising from differential lost to follow-up, which has not been mentioned in most of the studies. Second, the studied population varies from study to study, and some unknown confounders may not be effectively evaluated. Further evaluation of the effect of breastfeeding from an HBV infected mother and infantile CHB infection while taking into consideration of potential biases can be feasibly achieved with more large-scale prospective follow-up studies.
Breast milk is infectious; yet, breastfeeding, even by mothers with high infectivity, is not associated with demonstrable risk of infection of infantile CHB. This may be partly because infection mainly occurs during delivery and the protection by vaccination. The finding concurs with that of individual studies and supports the WHO recommendation of BF, irrespective of the HBV status of the mothers.
This work was supported by a grant from the Ministry of Science and Technology of the People's Republic of China (2008ZX10002-012) and the Shanghai Leading Academic Discipline Project (B118).
I thank Professor Munhon Ng for his critical reading of this manuscript, the reviewers for their helpful comments and Mr Peter Stephen Liu for English editing.
- Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004, 11 (2): 97-107. 10.1046/j.1365-2893.2003.00487.x.View ArticlePubMedGoogle Scholar
- Lok AS: Chronic hepatitis B. N Engl J Med. 2002, 346 (22): 1682-1683. 10.1056/NEJM200205303462202.View ArticlePubMedGoogle Scholar
- Lee CY, Huang LM, Chang MH, Hsu CY, Wu SJ, Sung JL, Safary A: The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers. Pediatr Infect Dis J. 1991, 10 (4): 299-303. 10.1097/00006454-199104000-00007.View ArticlePubMedGoogle Scholar
- Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, Eidelman AI: Breastfeeding and the use of human milk. Pediatrics. 2005, 115 (2): 496-506.View ArticlePubMedGoogle Scholar
- Linnemann CC, Goldberg S: HBAg in breast milk. Lancet. 1974, 155-2Google Scholar
- Petrova M, Kamburov V: Breastfeeding and chronic HBV infection: clinical and social implications. World J Gastroenterol. 2010, 16 (40): 5042-5046. 10.3748/wjg.v16.i40.5042.View ArticlePubMedPubMed CentralGoogle Scholar
- Ma L, Zhao GZ, Liang ZL: Relationship between load of HBV-DNA in serum and breast milk for pregnant women and safety of breastfeeding. China Journal of Modern Medicine. 2006, 16 (17): 2581-2585.Google Scholar
- Beasley RP, Stevens CE, Shiao IS, Meng HC: Evidence against breastfeeding as a mechanism for vertical transmission of Hepatitis B. Lancet. 1975, 2 (7938): 740-741.View ArticlePubMedGoogle Scholar
- Derso A, Boxall E, Tarlow M, Flewett T: Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J. 1978, 1 (6118): 949-952. 10.1136/bmj.1.6118.949.View ArticlePubMedPubMed CentralGoogle Scholar
- Hill J, Sheffield J, Kim M, Alexander J, Sercely B, Wendel G: Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol. 2002, 99 (6): 1049-1052. 10.1016/S0029-7844(02)02000-8.PubMedGoogle Scholar
- De Martino M, Appendino C, Resti M, Rossi ME, Muccioli AT, Vierucci A: Should hepatitis B surface antigen positive mothers breastfeed?. Arch Dis Child. 1985, 60: 972-974. 10.1136/adc.60.10.972.View ArticlePubMedPubMed CentralGoogle Scholar
- Tseng RY, Lam CW, Tam J: Breastfeeding babies of HBsAg-positive mothers. Lancet. 1988, 2 (8618): 1032-View ArticlePubMedGoogle Scholar
- Wang JS, Zhu QR, Wang XH: Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract. 2003, 57 (2): 100-102.PubMedGoogle Scholar
- World Health Organization: Hepatitis B and breastfeeding. J Int Assoc Physicians AIDS Care. 1998, 4 (7): 20-21.Google Scholar
- Giles ML, Garland SM, Grover SR, Lewin SM, Hellard ME: Impact of an education campaign on management in pregnancy of women infected with a blood-borne virus. Med J Aust. 2006, 184 (8): 389-392.PubMedGoogle Scholar
- Ahn J, Salem SB, Cohen SM: Evaluation and management of hepatitis B in pregnancy: a survey of current practices. Gastroenterol Hepatol (NY). 2010, 6 (9): 570-578.Google Scholar
- Lee C, Gong Y, Brok J, Boxall EH, Gluud C: Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006, 332 (7537): 328-336. 10.1136/bmj.38719.435833.7C.View ArticlePubMedPubMed CentralGoogle Scholar
- Wells G, Shea BO, Connell D: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2010, [http://www.ohri.ca/programs/clinical_epidemiology/oxford_web.ppt]Google Scholar
- Altman DG, Bland JM: Interaction revisited: the difference between two estimates. BMJ. 2003, 326 (7382): 219-10.1136/bmj.326.7382.219.View ArticlePubMedPubMed CentralGoogle Scholar
- Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50 (4): 1088-1101. 10.2307/2533446.View ArticlePubMedGoogle Scholar
- Duval S, Tweedie R: A Nonparametric "Trim and Fill" Method of Accounting for Publication Bias in Meta-Analysis. J Am Stat Assoc. 2000, 95 (449): 89-98. 10.2307/2669529.Google Scholar
- Huang YR, Guo CJ, Huang GH: Breastfeeding among HBsAg positive mothers: a report of 126 cases. The Journal of Clinical Pediatrics. 1993, 11 (5): 331-332.Google Scholar
- Wu MM, Su PM: A primary study on the breastfeeding among HBsAg positive mothers. Jiangsu Medical Journal. 1996, 22: 410-412.Google Scholar
- Zeng WT, Zhu KL, Ma PQ, Deng ZX, Wei JJ, Ye XM: Clinical study on the relationship between breastfeeding and HBV transmission. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases. 2001, 11 (1): 13-14.Google Scholar
- Wu MM, Tang YR, Guo CX, Fang ZX: Observation on the results of breastfeeding of hepatitis B carrier mothers after using active and passive immunization. Chinese Journal of Obstetrics and Gynecology. 2002, 235-236. 4Google Scholar
- Zeng YL, Wu J, Wang L, Hu R, Pu HM, Zhu LX: The safety of breastfeeding among the mothers positive in serum indices of hepatitis B virus. Sichuan Medical Journal. 2003, 24 (8): 823-824.Google Scholar
- Gu XQ, Shi LE, Han SP, Wu B, Sun HJ: Interruption of mother-to-infant transmission of hepatitis B virus and comparison of immunological effect of recombinant and blood derived hepatitis B vaccine. Journal of Applied Clinical Pediatrics. 2003, 18 (11): 895-897.Google Scholar
- He EX, Jiang LJ: The effect of breastfeeding on the infants borne of the mothers with hepatitis B. Inner Mongolia Medical Journal. 2004, 36 (5): 37-Google Scholar
- Liu DM, Wang XX: Clinical study on the transmission of heapatitis B virus through breast milk after combined active and passive immune-prophylaxis. Journal of Medical Reaserch. 2004, 22 (4): 56-57.Google Scholar
- Yao WQ, Li DH, Chen Y, Huang XD: The safety of breastfeeding among HBV carrier mothers after combined active and passive immunoprophylaxis. Chinese Journal of Practical Gynecology and Obstetrics. 2004, 20 (2): 109-110.Google Scholar
- Meng Z, Xiao XM, He MJ, Xu YY, Li Y: The application of HBIG to maternal women carring HBsAg and the effect of different feeding way to infants. The Journal of Practical Medicine. 2004, 20 (10): 1102-1104.Google Scholar
- Mou RL, Ma YY, Li H, Kong BH, Jiang S: Study on breastfeeding in hepatitis B virus carrier women. Chinese Journal of Perinatal Medicine. 2005, 8 (1): 20-23.Google Scholar
- Zhang HZ, Ma MX, Li X, Tian MQ: The effect of mother-to-infant transmission of hepatitis B through hepatitis B immunization among 304 cases. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases. 2005, 15 (5): 289-290.Google Scholar
- Zhang JH, Wang FL, Hu Y, Xu B, Ding AJ, Jiang L: An investigation on the safety of breastfeeding among infants born of hepatitis-B-virus-markers-positive mothers by active and passive immunization. Journal of Chongqing Medical University. 2005, 30 (2): 275-277.Google Scholar
- Qiu ZY: Investigation on breastfeeding of 90 maternal mothers with positive HBeAg. Zhejiang Journal of Preventive Medicine. 2005, 17 (9): 39-44.Google Scholar
- Zeng DY, Mo KL, He HY, Guan J, Fang ZY, Zhong H: Risk of HBV transmission in breast-fed infants of chronic HBV carriers after combined active and passive immunoprophylaxis. Progress in Obstetrics and Gynecology. 2006, 15 (2): 125-127.Google Scholar
- Chen JY: The investigation on breastfeeding of the mothers with hepatitis B virus. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine. 2006, 6 (2): 66-67.Google Scholar
- Zuo SE, Ma YL, Zhang QT, Wang LJ, Qiang GY: The safety of breastfeeding among HBV carriers after hepatitis B immunization. Maternal and Child Health Care of China. 2007, 22 (13): 1734-1735.Google Scholar
- Wang YL, Gu J, Zhao L: The relationship between breastfeeding and incidence of mother-to-infant transmission of hepatitis B virus: a report of 165 cases. Ningxia Medical Journal. 2007, 29 (5): 415-416.Google Scholar
- Qin RY, Shen BS: A clinical study on the safety of breastfeeding after immunoprophylaxis among positive HBsAg mothers. Maternal and Child Health Care of China. 2007, 22 (31): 4468-4469.Google Scholar
- Chen H, Han J, Yang HS: A contrast study on influence of different feeding and immunity patterns of HBsAg carriers on HBV horizontal transmission to their infants. Chinese Journal of Woman and Child Health Research. 2008, 19 (4): 316-318.Google Scholar
- Hou ZH, Yu WH, Zhou XM, Wang XL: Risk of vertical transmission through breastfeeding among chronic hepatitis B infection. International Journal of Laboratory Medicine. 2009, 1238-1239. 12Google Scholar
- Li Y: The safety study of breastfeeding among hepatitis B virus carrier mothers. Chinese Community Doctors. 2009, 16-17. 5Google Scholar
- Luo ZL, Zheng X: Study on the relationship between breastfeeding of HBsAg positive mothers and the transmission of hepatitis B virus to their infants. Fujian Medical Journal. 2010, 32 (5): 45-47.Google Scholar
- Chen FJ, Qi ZB, Wang J: Impact of HBV-DNA levels on the blocking of transmission of hepatitis B from mothers to babies by injection of hepatitis B immunoglobulin. China Tropical Medicine. 2010, 10 (12): 45-47.Google Scholar
- Sun LY, Zhao ZM, Liu C: The safety of breastfeeding by the mothers with HBV infection. China Modern Doctor. 2010, 48 (3): 138-139.Google Scholar
- Liu GX, Zheng AH, Chen SN: Safety of breastfeeding in infants of HBV carrier mothers after combined active and passive immunoprophylaxis in both mothers and infants. Chinese Journal of Modern Drug Application. 2010, 4 (12): 9-10.Google Scholar
- Wu YH: Serum HBV-DNA level and safety of breastfeeding. China Modern Doctor. 2010, 48 (29): 89-90.Google Scholar
- Ranger-Rogez S, Denis F: Hepatitis B mother-to-child transmission. Expert Rev Anti Infect Ther. 2004, 2 (1): 133-145. 10.1586/14787220.127.116.11.View ArticlePubMedGoogle Scholar
- Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J: Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol. 2003, 71 (3): 360-366. 10.1002/jmv.10493.View ArticlePubMedGoogle Scholar
- Ordog K, Szendroi A, Szarka K, Kugler Z, Csire M, Kapusinszky B, Xie J, Csizmadia K, Brojnas J, Rusvai E, Tempfli A, Berencsi G: Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population. J Med Virol. 2003, 70 (2): 194-204. 10.1002/jmv.10378.View ArticlePubMedGoogle Scholar
- Tang XM, Xiao XM: Meta-analysis on the safety of breastfeeding on the infants of HBV carrier mothers. Maternal and Child Health Care of China. 2007, 22 (29): 4193-4195.Google Scholar
- Liu ZQ: The effect of feeding methods on infant transmission of hepatitis B virus after combined immunoprophylaxis: a meta analysis. 2009, Zhejiang UniversityGoogle Scholar
- Qiu L, Binns CW, Zhao Y, Zhang K, Xie X: Hepatitis B and breastfeeding in Hangzhou, Zhejiang Province, People's Republic of China. Breastfeed Med. 2010, 5 (3): 109-112. 10.1089/bfm.2009.0093.View ArticlePubMedGoogle Scholar
- Guo Y, Liu J, Meng L, Meina H, Du Y: Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission. BMC Infect Dis. 2010, 10: 26-10.1186/1471-2334-10-26.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://0-www.biomedcentral.com.brum.beds.ac.uk/1471-2458/11/502/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.